Nanochemistry is an emerging sub-discipline of the chemical and material sciences that deals with the development of new methods for creating nanoscale materials. The term "nanochemistry" was first used by Ozin in 1992 as 'the uses of chemical synthesis to reproducibly afford nanomaterials from the atom "up", contrary to the nanoengineering and nanophysics approach that operates from the bulk "down"'. Nanochemistry focuses on solid-state chemistry that emphasizes synthesis of building blocks that are dependent on size, surface, shape, and defect properties, rather than the actual production of matter. Atomic and molecular properties mainly deal with the degrees of freedom of atoms in the periodic table. However, nanochemistry introduced other degrees of freedom that controls material's behaviors by transformation into solutions. Nanoscale objects exhibit novel material properties, largely as a consequence of their finite small size. Several chemical modifications on nanometer-scaled structures approve size dependent effects.
The Health Protection Agency (HPA) was a non-departmental public body in the United Kingdom. It was an organisation that was set up by the UK government in 2003 to protect the public from threats to their health from infectious diseases and environmental hazards.
Eric Jeffrey Topol is an American cardiologist, scientist, and author. He is the founder and director of the Scripps Research Translational Institute, a professor of Molecular Medicine at The Scripps Research Institute, and a senior consultant at the Division of Cardiovascular Diseases at Scripps Clinic in La Jolla, California. He is editor-in-chief of Medscape and theheart.org. He has published three bestseller books on the future of medicine: The Creative Destruction of Medicine (2010), The Patient Will See You Now (2015), and Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again (2019). He was also commissioned by the UK 2018–2019 to lead planning for the National Health Service's future workforce, integrating genomics, digital medicine, and artificial intelligence.
The Center for Infectious Disease Research and Policy (CIDRAP) is a center within the University of Minnesota that focuses on addressing public health preparedness and emerging infectious disease response. It was founded in 2001 by Dr. Michael Osterholm, in order to "prevent illness and death from infectious diseases through epidemiological research and rapid translation of scientific information into real-world practical applications and solutions".
Rashid Bashir is Dean of The Grainger College of Engineering, Grainger Distinguished Chair in Engineering and Professor of Bioengineering, at the University of Illinois at Urbana-Champaign. He was the Executive Associate Dean and Chief Diversity Officer at the Carle-Illinois College of Medicine at UIUC. Previously, he was the Abel Bliss Professor of Engineering, Head of Department of Bioengineering, Director of the Micro and Nanotechnology Laboratory, and Co-Director of the campus-wide Center for Nanoscale Science and Technology, a "collaboratory" aimed at facilitating center grants and large initiatives around campus in the area of nanotechnology. Prior to joining UIUC, he was at Purdue University from 1998–2007 with faculty appointments in Electrical and Computer Engineering, and Bioengineering. From 1992 to 1998 he worked at National Semiconductor Corporation in Santa Clara, CA as Sr. Engineering Manager. He graduated with a PhD in Electrical Engineering from Purdue University in 1992. He has authored or co-authored over 240 journal papers, over 200 conference papers and conference abstracts, and over 120 invited talks, and has been granted 50 patents. He is an NSF Faculty Early Career Award winner and the 2012 IEEE EMBS Technical Achievement Award. He received the Pritzker Lecture Award from BMES in 2018. He is a fellow of IEEE, AIMBE, AAAS, BMES, RSC, APS, and NAI.
Sir Jeremy James Farrar is a British medical researcher who has served as director of the Wellcome Trust since 2013 and will serve as chief scientist at the World Health Organization in 2023. He was previously a professor of tropical medicine at the University of Oxford.
Genomics England is a British company set up and owned by the United Kingdom Department of Health and Social Care to run the 100,000 Genomes Project. The project aimed in 2014 to sequence 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. An infectious disease strand is being led by Public Health England.
The 100,000 Genomes Project is a now-completed UK Government project managed by Genomics England that is sequencing whole genomes from National Health Service patients. The project is focusing on rare diseases, some common types of cancer, and infectious diseases. Participants give consent for their genome data to be linked to information about their medical condition and health records. The medical and genomic data is shared with researchers to improve knowledge of the causes, treatment, and care of diseases.
Ambika Bumb an American biomedical scientist and businessperson. Bumb is a nanomedicine specialist who uses nanotechnology for the detection of treatment of disease. Her discoveries using nanodiamonds while working as postdoctoral researcher at the National Cancer Institute and the National Heart, Lung, and Blood Institute led to the launch of the biotech Bikanta.
Sharon Jayne Peacock is a British microbiologist who is Professor of Public Health and Microbiology in the Department of Medicine at the University of Cambridge.
Health Innovation Manchester is an academic health science centre established in October 2017 to drive innovation in healthcare in Greater Manchester. It is closely associated with the Greater Manchester Health and Social Care Partnership.
Caitlin M. Rivers is an American epidemiologist who as Senior Scholar at the Johns Hopkins Center for Health Security and assistant professor at the Johns Hopkins Bloomberg School of Public Health, specializing on improving epidemic preparedness. Rivers is currently working on the American response to the COVID-19 pandemic with a focus on the incorporation of infectious disease modeling and forecasting into public health decision making.
Allison Joan McGeer is a Canadian infectious disease specialist in the Sinai Health System, and a professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. She also appointed at the Dalla Lana School of Public Health and a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute, and is a partner of the National Collaborating Centre for Infectious Diseases. McGeer has led investigations into the severe acute respiratory syndrome outbreak in Toronto and worked alongside Donald Low. During the COVID-19 pandemic, McGeer has studied how SARS-CoV-2 survives in the air and has served on several provincial committees advising aspects of the Government of Ontario's pandemic response.
Alison Helen Holmes is a British infectious diseases specialist, who is a professor at Imperial College London. Holmes serves as Director of the National Institute for Health Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance and Consultant at Hammersmith Hospital. Holmes is on the Executive Committee of the International Society of Infectious Diseases, and she serves on a variety of World Health Organization (WHO) expert groups related to antimicrobial use, Antimicrobial Resistance (AMR), infection prevention and sepsis. Her research considers how to mitigate antimicrobial resistance.
Eleni Nastouli is a Greek clinical virologist who works at University College London Hospitals NHS Foundation Trust (UCLH) and Great Ormond Street Hospital. At UCLH, Nastouli leads the Advanced Pathogen Diagnostics Unit, where she develops technologies for genome sequencing as well as studying how viruses are transmitted around hospitals. During the COVID-19 pandemic Nastouli led an investigation into infection rates amongst healthcare workers.
Ester H. Segal is an Israeli nanotechnology researcher and professor in the Department of Biotechnology and Food Engineering at the Technion - Israel Institute of Technology, where she heads the Laboratory for Multifunctional Nanomaterials. She is also affiliated with the Russell Berrie Nanotechnology Institute at the Technion - Israel Institute of Technology. Segal is a specialist in porous silicon nanomaterials, as well as nanocomposite materials for active packaging technologies to extend the shelf life of food.
Robin Patel is a Canadian born microbiologist and was the 2019–2020 President of the American Society for Microbiology (ASM). She is the Elizabeth P. and Robert E. Allen Professor of Individualized Medicine, a Professor of Microbiology, and a Professor of Medicine at the Mayo Clinic. She is the Vice Chair of Education in the Department of Laboratory Medicine and Pathology at the Mayo Clinic, and Director of the Mayo Clinic's Infectious Diseases Research Laboratory, where she studies biofilms, antimicrobial resistance, periprosthetic joint infection and diagnostic testing of bacteria. She is the Director of the Antibacterial Resistance Leadership Group (ARLG) Laboratory Center of the National institutes of Health.
Long COVID or long-haul COVID is a condition characterized by long-term health problems persisting or appearing after the typical recovery period of COVID-19. Although studies into long COVID are under way, as of May 2022 there is no consensus on the definition of the term.
Susan Hopkins CBE is an Irish epidemiologist and civil servant working in the UK. She is honorary clinical senior lecturer in the Department of Medicine at Imperial College London, and Chief Medical Advisor for the UK Health Security Agency (UKHSA).
